Drug Trial Radar · NCT07774403
A Study of AZD0292 in Chinese Participants With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization
Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
84
Planned (sponsor's estimate)
Start
Jun 24, 2026
Primary completion
Jan 18, 2028
Study completion Jun 6, 2028
Sponsor
- Lead sponsor
- AstraZenecaAstraZeneca (AZN)
- Sponsor type
- Industry
- First posted
- Aug 19, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
AZD0292 is a bispecific IgG1k mAb being evaluated for the prevention of exacerbations in bronchiectasis patients chronically colonized with PsA.
Conditions
- Bronchiectasis With Pseudomonas Aeruginosa Colonization
Interventions
AZD0292Drug
AZD0292 administered starting on Day 1 via IV infusion, subsequent administrations per schedule of assessments.
PlaceboOther
Placebo administered starting on Day 1 via IV infusion, subsequent administrations per schedule of assessments.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Annualized rate of exacerbations over a variable follow-up timeTime frame: Min 28 weeks, max 52 weeks
Locations
40 sites in 1 country. Site status is shown where the registry gives one.
Research Site
Anyang, China · Recruiting
Research Site
Beijing, China · Recruiting
Research Site
Beijing, China · Recruiting
Research Site
Beijing, China · Recruiting
Research Site
Changsha, China · Recruiting
Research Site
Chengdu, China · Recruiting
Research Site
Chengdu, China · Recruiting
Research Site
Chengdu, China · Recruiting
Research Site
Chizhou, China · Recruiting
Research Site
Haikou, China · Recruiting
Research Site
Hefei, China · Recruiting
Research Site
Hohhot, China · Recruiting
Research Site
Hohhot, China · Recruiting
Research Site
Jinan, China · Recruiting
Research Site
Jinhua, China · Recruiting
Research Site
Jining, China · Recruiting
Research Site
Kunming, China · Recruiting
Research Site
Langfang, China · Recruiting
Research Site
Linhai, China · Recruiting
Research Site
Liuzhou, China · Recruiting
Research Site
Nanchang, China · Recruiting
Research Site
Nanchang, China · Recruiting
Research Site
Nanning, China · Recruiting
Research Site
Shanghai, China · Recruiting
Research Site
Shanghai, China · Recruiting
Research Site
Shanghai, China · Recruiting
Research Site
Shanghai, China · Recruiting
Research Site
Shanghai, China · Recruiting
Research Site
Shenyang, China · Recruiting
Research Site
Taicang, China · Recruiting
Research Site
Taizhou, China · Recruiting
Research Site
Wenzhou, China · Recruiting
Research Site
Xinxiang, China · Recruiting
Research Site
Xuzhou, China · Recruiting
Research Site
Zaozhuang, China · Recruiting
Research Site
Zhangzhou, China · Recruiting
Research Site
Zhengzhou, China · Recruiting
Research Site
Zhengzhou, China · Recruiting
Research Site
Zhuzhou, China · Recruiting
Research Site
Zibo, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.